Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Medicus Pharma Ltd (MDCX : NSDQ)

• Company Description    Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario. Number of Employees: 12

• Price / Volume Information    Yesterday's Closing Price: $1.89 Daily Weekly Monthly 20 Day Moving Average: 344,472 shares Shares Outstanding: 22.03 (millions) Market Capitalization: $41.63 (millions) Beta: 52 Week High: $8.94 52 Week Low: $1.68 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -16.37% -17.47% 12 Week -22.22% -24.45% Year To Date -22.22% -31.61%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 300 CONSHOHOCKEN STATE RD. SUITE 200 - W. CONSHOHOCKEN,PA 19428 USA ph: 610-636-0184 fax: - ir@medicuspharma.com https://medicuspharma.com

• General Corporate Information    Officers Raza Bokhari - Chief Executive Officer and Executive Chairman James Quinlan - Chief Financial Officer Larry Kaiser - Director Robert J. Ciaruffoli - Director Frank Lavelle - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 58471K202 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/27/26 Share - Related Items Shares Outstanding: 22.03 Most Recent Split Date: (:1) Beta: Market Capitalization: $41.63 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.37 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.86 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/27/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -109.68% vs. Previous Quarter: -51.16% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 09/30/25 - -1,077.62 06/30/25 - -549.30 03/31/25 - -380.03 ROA 09/30/25 - -250.67 06/30/25 - -228.06 03/31/25 - -224.22 Current Ratio 09/30/25 - 0.92 06/30/25 - 1.29 03/31/25 - 1.53 Quick Ratio 09/30/25 - 0.92 06/30/25 - 1.29 03/31/25 - 1.53 Operating Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Net Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Pre-Tax Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Book Value 09/30/25 - -0.05 06/30/25 - 0.20 03/31/25 - 0.16 Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Equity 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©